Acetazolamida
Aldesleukina
Alendronato
Aluminio, hidróxido
Bumetanida
Carboplatino
Cisplatino
Corticotropina
Estreptozocina
Imatinib
|
Indapamida
Micofenolato
Niacina
Pamidronato
Plicamicina
Risedronato
Teofilina
Sucralfato
Tacrolimus
Tenofovir |
REFERENCIAS
- Buchacz K, Brooks JT, Tong T, Moorman AC, Baker RK, Holmberg SD, Greenberg A. Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy. HIV Medicine, (2006), Vol. 7 Issue 7, p451-456,
- Berman E. Altered bone and mineral metabolism in patients receiving imatinib mesylate. N Engl J Med (2006) May 11; Vol. 354 (19), pp. 2006-13
|